XML 75 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:        
Research and development $ 97,421 $ 47,679 $ 228,191 $ 117,825
General and administrative 15,605 10,898 43,174 27,858
Total operating expenses 113,026 58,577 271,365 145,683
Loss from operations (113,026) (58,577) (271,365) (145,683)
Other income (expense), net:        
Interest Expense 0 0 0 (2)
Interest income 18,495 1,190 45,339 1,723
Grant income 1,640 157 4,759 1,006
Foreign currency transaction gains (losses) 227 (687) (198) (2,479)
Total other income, net 20,362 660 49,900 248
Net loss $ (92,664) $ (57,917) $ (221,465) $ (145,435)
Net loss per share, basic $ (0.91) $ (0.93) $ (2.32) $ (2.42)
Net loss per share, diluted $ (0.91) $ (0.93) $ (2.32) $ (2.42)
Weighted-average shares outstanding, basic 101,668,655 61,989,347 95,367,751 60,166,583
Weighted-average shares outstanding, diluted 101,668,655 61,989,347 95,367,751 60,166,583